Development and validation of an LC/MS/MS method for determination of valproic acid and its metabolite 2-propyl-4-pentenoic acid in monkey plasma

Journal of the Korean Society for Applied Biological Chemistry

Volumn 55, Issue 1, 2012, Pages 13-17

  Hwang, Kyunghwa ^a   Song, Sun Sook ^a   Lee, Ju Hee ^a   Shin, Min Chul ^a   Seo, Jong Su ^a  

^a Korea Institute of Toxicology   (South Korea)

Author keywords

2 propyl 4 pentenoic acid; liquid chromatography mass spectrometry (MS) MS; method validation; valproic acid

Indexed keywords

HAPLORHINI;

EID: 84862837992     PISSN: 17382203     EISSN: 2234344X     Source Type: Journal    
DOI: 10.1007/s13765-012-0003-6     Document Type: Article

References (15)

1. Amini-Shirazi N, Ahmadkhaniha R, Shadnia S, Ghahremani MH, Abdollahi M, Dadgar A, and Kebriaeezadeh A (2010) Determination of VPA and its Two Important Metabolites in Iranian Overdosed Patients. Int J Pharm6, 854-862.
2. Cheng H, Liu Z, Blum W, Byrd JC, Klisovic R, Grever MR, Marcucci G, and Chan KK (2007) Quantification of valproic acid and its metabolite 2-propyl-4-pentenoic acid in human plasma using HPLC-MS/MS. J Choromatogr850, 206-212.
3. Davis R, Peters DH, and McTavish D (1994) Valproic aicd. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy. Drugs47, 332-372.
4. Granneman GR, Wang SI, Machinist JM, and Kesterson JW (1984) Aspects of the metabolism of valproic acid. Xenobiotica14, 375-387.
5. Jain DS, Subbaiah G, Sanyal M, and Shivastav P (2007) A high throughput and selective method for the estimation of valproic acid an antiepileptic drug in human plasma by tandem LC-MS/MS. Talanta72, 80-88.
6. Lucarelli C, Villa P, Lombardi E, Prandini P, and Brega A (1992) HPLC Method for the Simultaneous Analysis of Valproic Acid and other Common Anticonvulsant Drugs in Human Plasma or Serum. Chromatographia33, 37-40.
7. Matsuura K, Ohmori T, Nakamura M, Itoh Y, and Hirano K (2008) A simple and rapid determination of valproic acid in human plasma using a nonporous silica column and liquid chromatography with tandem mass spectrometric detection. Biomed Chromatogr22, 387-393.
8. Nakamura M, Kondo K, Nishioka R, and Kawai S (1984) Improved procedure for the high-performance liquid chromatographic determination of valproic acid in serum as its phenacyl ester. J Chromatogr310, 450-454.
9. Pucci V, Monteagudo E, and Bonelli F (2005) High sensitivity determination of valproic acid in mouse plasma using semi-automated sample preparation and liquid chromatography with tandem mass spectrometric detection. Rapid Commun Mass Spectrom19, 3713-3718.
10. Ramakrishna NVS, Vishwottam KN, Manoj S, Koteshwara M, Santosh M, Chidambara J, and Kumar BR (2005) Liquid chromatography/electrospray ionization mass spectrometry method for the quantification of valproic acid in human plasma. Rapid Commun Mass Spectrom19, 1970-1978.
11. Rettenmeier AW, Gordon WP, Prickett KS, Levy RH, and Baillie TA (1986) Biotransformation and pharmacokinetics in the rhesus monkey of 2-n-propyl-4-pentenoic acid, a toxic metabolite of valproic acid. Drug Metab Dispos14, 454-464.
12. Vam der Horst FA, Eikelboom GG, and Holthuis JJ (1988) High-performance liquid chromatographic determination of valproic acid in plasma using a micelle-mediated pre-column derivatization. J Chromatogr456, 191-199.
13. Willmore LJ (2003) Divalproex and epilepsy. Psychopharmacol Bull37, 43-53.
14. Wolf JH, Veenma-van der Duin L, and Korf J (1989) Automated analysis procedure for valproic acid in blood, serum and brain dialysate by high-performance liquid chromatography with bromomethylmethoxycoumarin as fluorescent label. J Chromatogr487, 496-502.
15. Zimmerman HJ and Ishak KG (1982) Valproate-induced hepatic steatogenesis in rats. Hepatology2, 591-597.